Two Former Executive Of Sinopharm Detained For Suspected Corruption
This article was originally published in PharmAsia News
Sinopharm announced Jan. 10 that its former director, Shi Jinming, was detained for investigation of corruption by the People’s Procuratorate in Shanghai.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.